A prognostic scoring system for conversion surgery after trastuzumab-based chemotherapy for human epidermal growth factor receptor 2-positive advanced gastric cancer

被引：0
|
作者：
Takaaki Arigami
Daisuke Matsushita
Keishi Okubo
Masataka Shimonosono
Ken Sasaki
Yusuke Tsuruda
Yoshiaki Kita
Kan Tanabe
Shinichiro Mori
Shigehiro Yanagita
Yoshikazu Uenosono
Akihiro Nakajo
Hiroshi Kurahara
Takao Ohtsuka
机构：
[1] Kagoshima University Graduate School of Medical and Dental Sciences,Department of Onco
[2] Kagoshima University Graduate School of Medical and Dental Sciences,Biological Surgery
来源：
Surgery Today | 2022年 / 52卷
关键词：
Gastric cancer; Conversion surgery; Prognosis; Trastuzumab; HER2;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1721 / 1730
页数：9
相关论文
共 50 条
  • [31] Trastuzumab Beyond Progression in Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: UK Practice now and in the Future
    Robinson, T.
    Palmieri, C.
    Braybrooke, J. P.
    CLINICAL ONCOLOGY, 2020, 32 (10) : 636 - 638
  • [32] Rare case of human epidermal growth factor receptor 2-positive gastric remnant cancer after bariatric surgery-case report
    Wagner, Carolin-Sophie
    Schartner, Melanie
    Nehoda, Hermann
    Rainer, Peter P.
    Schnallinger, Michael
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2025, 18 (01) : 63 - 67
  • [33] Impact of Trastuzumab on Ipsilateral Breast Tumor Recurrence for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer after Breast-Conserving Surgery
    Cheun, Jong Ho
    Won, Jiyoung
    Jung, Ji Gwang
    Kim, Hong Kyu
    Han, Wonshik
    Lee, Han Byoel
    JOURNAL OF BREAST CANCER, 2021, 24 (03) : 301 - 314
  • [34] Quantifying the Effects of Combination Trastuzumab and Radiation Therapy in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer
    Bloom, Meghan J.
    Song, Patrick N.
    Virostko, John
    Yankeelov, Thomas E.
    Sorace, Anna G.
    CANCERS, 2022, 14 (17)
  • [35] Trastuzumab-Based Combination Chemotherapy in Patients with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Carcinoma ex Pleomorphic Adenoma
    Arihara, Yohei
    Murase, Kazuyuki
    Takada, Kohichi
    Hayasaka, Naotaka
    Miura, Shogo
    Miyanishi, Koji
    Kobune, Masayoshi
    Kurose, Makoto
    Akiyama, Yukinori
    Sugita, Shintaro
    Kato, Junji
    CASE REPORTS IN ONCOLOGY, 2018, 11 (03): : 835 - 841
  • [36] Trastuzumab Emtansine in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: An Integrated Safety Analysis
    Dieras, Veronique
    Harbeck, Nadia
    Budd, G. Thomas
    Greenson, Joel K.
    Guardino, Alice E.
    Samant, Meghna
    Chernyukhin, Nataliya
    Smitt, Melanie C.
    Krop, Ian E.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (25) : 2750 - +
  • [37] Emerging role of biosimilars: Focus on trastuzumab and metastatic human epidermal growth factor receptor 2-positive breast cancer
    Sarder, Lyudmila U.
    Ahmad, Sarfraz
    RESULTS IN CHEMISTRY, 2023, 6
  • [38] A phase I study of pharmacokinetics of trastuzumab emtansine in Chinese patients with locally advanced inoperable or metastatic human epidermal growth factor receptor 2-positive breast cancer who have received prior trastuzumab-based therapy
    Ji, Dongmei
    Shen, Weina
    Zhang, Jian
    Cao, Junning
    Li, Wenhua
    Lam, Lisa H.
    Wu, Fan
    Wang, Bei
    Li, Zao
    Sun, Guofang
    Hu, Xichun
    Chen, Shang-Chiung
    MEDICINE, 2020, 99 (44) : E22886
  • [39] Prognostic Factors in Patients with Advanced HER2-Positive Gastric Cancer Treated with Trastuzumab-Based Chemotherapy: a Cohort Study
    Shoko Marshall
    Takeru Wakatsuki
    Daisuke Takahari
    Tomohiro Matsushima
    Naoki Ishizuka
    Izuma Nakayama
    Hiroki Osumi
    Mariko Ogura
    Takashi Ichimura
    Eiji Shinozaki
    Keisho Chin
    Kensei Yamaguchi
    Journal of Gastrointestinal Cancer, 2023, 54 : 475 - 484
  • [40] Prognostic Factors in Patients with Advanced HER2-Positive Gastric Cancer Treated with Trastuzumab-Based Chemotherapy: a Cohort Study
    Marshall, Shoko
    Wakatsuki, Takeru
    Takahari, Daisuke
    Matsushima, Tomohiro
    Ishizuka, Naoki
    Nakayama, Izuma
    Osumi, Hiroki
    Ogura, Mariko
    Ichimura, Takashi
    Shinozaki, Eiji
    Chin, Keisho
    Yamaguchi, Kensei
    JOURNAL OF GASTROINTESTINAL CANCER, 2023, 54 (02) : 475 - 484
12345